rosiglitazone has been researched along with alpha-aminopyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujieda, H; Makishima, M; Miyata, N; Nakagawa, H; Ogura, M; Suzuki, T; Usui, S; Yoshida, N | 1 |
| Anthony, J; Bhumra, SK; Deka, N; Kelkar, A; Marita, AR; Mutt, S; Mutt, SJ; Ranjith, V; Sharma, S; Sivaramakrishnan, H; Wilankar, C | 1 |
| Gao, R; Guo, T; Hu, X; Li, J; Liu, Z; Mei, H; Ming, Y; Song, Y; Wang, B; Wu, C; Xiao, L; Xiao, X; Zhang, Y | 1 |
3 other study(ies) available for rosiglitazone and alpha-aminopyridine
| Article | Year |
|---|---|
Synthesis and evaluation of 2-Nonylaminopyridine derivatives as PPAR ligands.
Topics: Adipocytes; Aminopyridines; Cell Differentiation; Cell Line; Cells, Cultured; Drug Evaluation, Preclinical; Humans; Ligands; Molecular Structure; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Thiazolidinediones | 2007 |
Discovery of p1736, a novel antidiabetic compound that improves peripheral insulin sensitivity in mice models.
Topics: Adipocytes; Aminopyridines; Animals; Diabetes Mellitus, Type 2; Drug Discovery; Glucose; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Mice; Mice, Mutant Strains; Rosiglitazone; Sulfonamides; Thiazolidinediones | 2013 |
CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipose Tissue, White; Aminopyridines; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Polarity; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; PPAR gamma; Rosiglitazone; Thiazolidinediones; Transcriptional Activation | 2014 |